Xencor, Inc. - stock earnings
XNCR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -19.1 million USD | 44.7 million USD |
| 2023Q3 | -24.3 million USD | 59.2 million USD |
| 2023Q2 | -22.0 million USD | 45.5 million USD |
| 2023Q1 | -59.9 million USD | 19.0 million USD |
| 2022Q4 | -12.0 million USD | 21.6 million USD |
| 2022Q3 | -32.8 million USD | 27.3 million USD |
| 2022Q2 | -40.0 million USD | 30.2 million USD |
| 2022Q1 | 23.6 million USD | 85.5 million USD |
| 2021Q4 | 73.1 million USD | 154.0 million USD |
| 2021Q3 | -40.2 million USD | 19.7 million USD |
| 2021Q2 | 52.2 million USD | 67.4 million USD |
| 2021Q1 | -2.5 million USD | 34.0 million USD |
| 2020Q4 | -13.7 million USD | 41.9 million USD |
| 2020Q3 | -12.6 million USD | 35.4 million USD |
| 2020Q2 | -35.0 million USD | 13.1 million USD |
| 2020Q1 | -8.1 million USD | 32.4 million USD |
| 2019Q4 | -26.9 million USD | 3.5 million USD |
| 2019Q3 | -10.2 million USD | 21.8 million USD |
| 2019Q2 | -16.0 million USD | 19.5 million USD |
| 2019Q1 | 80.0 million USD | 111.9 million USD |
| 2018Q4 | -18.2 million USD | 11.6 million USD |
| 2018Q3 | 3.2 million USD | 29.0 million USD |
| 2018Q2 | -25.9 million USD | ? USD |
| 2018Q1 | -29.5 million USD | ? USD |
| 2017Q4 | -11.8 million USD | 10.9 million USD |
| 2017Q3 | -15.6 million USD | 7.1 million USD |
| 2017Q2 | -6.9 million USD | 13.3 million USD |
| 2017Q1 | -14.6 million USD | 4.3 million USD |
| 2016Q4 | -9.1 million USD | 6.4 million USD |
| 2016Q3 | -8.1 million USD | 7.8 million USD |
| 2016Q2 | 47.2 million USD | 66.0 million USD |
| 2016Q1 | -6.4 million USD | 7.3 million USD |
| 2015Q4 | 7.8 million USD | 21.8 million USD |
| 2015Q3 | -10.0 million USD | 3.5 million USD |
| 2015Q2 | -8.9 million USD | 1.0 million USD |
| 2015Q1 | -6.4 million USD | 1.5 million USD |
| 2014Q4 | -1.4 million USD | 5.7 million USD |
| 2014Q3 | -6.3 million USD | 848000 USD |
| 2014Q2 | -5.0 million USD | 824000 USD |
| 2014Q1 | -3.8 million USD | 2.2 million USD |
| 2013Q4 | -3.7 million USD | 1.7 million USD |
| 2013Q3 | -1.8 million USD | 3.2 million USD |
| 2013Q2 | -50.1 million USD | 3.9 million USD |
| 2013Q1 | -4.6 million USD | 1.3 million USD |
| 2012Q4 | -3.1 million USD | 2.4 million USD |
| 2012Q3 | -2.6 million USD | 1.6 million USD |
XNCR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -126.1 million USD | 168.3 million USD |
| 2022 | -55.2 million USD | 164.6 million USD |
| 2021 | 82.6 million USD | 275.1 million USD |
| 2020 | -63.5 million USD | 122.7 million USD |
| 2019 | 26.9 million USD | 156.7 million USD |
| 2018 | -70.4 million USD | 40.6 million USD |
| 2017 | -48.9 million USD | 35.7 million USD |
| 2016 | 23.6 million USD | 87.5 million USD |
| 2015 | -17.6 million USD | 27.8 million USD |
| 2014 | -16.4 million USD | 9.5 million USD |
| 2013 | -60.3 million USD | 10.2 million USD |
| 2012 | -8.6 million USD | 9.5 million USD |
| 2011 | -11.2 million USD | 6.8 million USD |
XNCR
Price: $24.11
52 week price:
Earnings Per Share: -2.08 USD
P/E Ratio: -9.33
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 500400
Ebitda: -14.8 millionMarket Capitalization: 1.3 billion